Wanbangde Pharmaceutical Group Co., LTD

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	NCT ID
Pharmacokinetics of Huperzine A Oral Solution in Healthy Participants	Healhty	Not yet recruiting	Phase 1	2026-08-25	NCT07784335
Clinical Study to Evaluate the Efficacy and Safety of Huperzine A Controlled-Release Tablets in Patients With Mild-to-Moderate Dementia of the Alzheimer's Type	Alzheimer disease, brain disorder, central nervous system disorder, cognitive disorder, dementia, nervous system disorder, neurodegenerative disease, psychiatric disorder, tauopathy	Recruiting	Phase 2 / Phase 3	2026-08-17	NCT07066826
The Study of Ginkgo Leaf Dropping Pills and Huperzine A Injection Combined With Median Nerve Electrical Stimulation in the Treatment of Cognitive Impairment After Brain Injury	Cognitive Impairment After Brain Injury	Recruiting	Phase 4	2026-08-17	NCT06704334
The Effect of Huperzine A Injection on Postoperative Cognitive Dysfunction in Patients With Aneurysmal Subarachnoid Hemorrhage: a Pilot Study	Postoperative Cognitive Dysfunction in Patients With Aneurysmal Subarachnoid Hemorrhage	Not yet recruiting	Phase 4	2026-08-17	NCT05560373

Clinical trials